Fatty liver disease (MASLD/MASH): open trials in India

• NCT07391267

  Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.

  Trial Treatment · Institute of Liver and Biliary Sciences, India

  Institute of Liver and Biliary Sciences, New Delhi

  Registry updated 2026-11-09

• NCT06215716

  A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

  Trial Treatment · Phase 3 · Akero Therapeutics, Inc

  Chandigarh · Coimbatore · Dahegaon · Hyderabad · Jaipur · Kolkata · Mumbai · Mysore · Nagpur · New Delhi · Pune · Secunderabad · Surat · Thiruvananthapuram · Vadodara · Varanasi

  Registry updated 2026-11-06

• NCT06632444

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  Trial Treatment · Phase 3 · Boehringer Ingelheim

  Aryav Superspeciality Hospital, Ahemdabad · Post Graduate Institute of Medical Education and Research, Chandigarh · Osmania Medical College & Hospital, Hyderabad, Afzalgunj · SR Kalla Memorial Hospital, Jaipur · ManglamPlus Medicity Hospital, Jaipur · Atharva Multispecialty Hospital and research Centre, Lucknow · Fortis Hospital, Mohali, Mohali · Midas Multispeciality Hospital Pvt.Ltd., Nagpur · Insitute of Liver and Billiary Sciences, New Delhi · All India Institute of Medical Sciences, New Delhi · Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak · Yashoda Hospitals - Secunderabad, Secunderabad · BAPS Pramukh Swami Hospital, Surat · Surat Institute of Digestive Sciences, Surat · Gujarat Gastro and Vascular Hospital, Surat

  Registry updated 2026-10-28

• NCT06632457

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  Trial Treatment · Phase 3 · Boehringer Ingelheim

  Aryav Superspeciality Hospital, Ahemdabad · Post Graduate Institute of Medical Education and Research, Chandigarh · Osmania Medical College & Hospital, Hyderabad, Afzalgunj · SR Kalla Memorial Hospital, Jaipur · Atharva Multispecialty Hospital and research Centre, Lucknow · Midas Multispeciality Hospital Pvt.Ltd., Nagpur · Insitute of Liver and Billiary Sciences, New Delhi · Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak · Yashoda Hospitals - Secunderabad, Secunderabad · BAPS Pramukh Swami Hospital, Surat · Surat Institute of Digestive Sciences, Surat · Gujarat Gastro and Vascular Hospital, Surat

  Registry updated 2026-10-28

• NCT07902219

  Qurse Revand for MASLD: A Randomized Controlled Safety and Efficacy Trial

  Trial Treatment · Phase 2 · National Institute of Unani Medicine, Bengaluru

  National Institute of Unani Medicine Bangalore, Bangalore

  Registry updated 2026-10-28

• NCT06318169

  A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Allahābād · Bhubaneswar · Gujrāt · Guwahati · Kolkata · Nagpur · New Delhi · Sūrat · Wardha

  Registry updated 2026-10-23

• NCT06419374

  A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Gujrāt · Prayagraj · Rajpur Sonarpur · Sūrat · Wardha

  Registry updated 2026-10-23

• NCT06528314

  A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  Trial Treatment · Phase 3 · Akero Therapeutics, Inc

  Chandigarh · Coimbatore · Hyderabad · Jaipur · Kolkata · Ludhiana · Mumbai · Mysore · Nagpur · New Delhi · Pune · Rishikesh · Surat · Thiruvananthapuram · Vadodara · Varanasi

  Registry updated 2026-10-13

• NCT07165028

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Avron Hospitals, Ahmedabad · All India Institute of Medical Sciences, Bhubaneswar · Postgraduate Institute of Medical Education & Research, Chandigarh · Amrita Institute of Medical Sciences and Research Center, Ernākulam · Endolife Speciality Hospitals, Guntur · Asian Institute Of Gastroenterology, Hyderabad · SR Kalla Memorial Gastro & General Hospital, Jaipur · Lisie Hospital, Kochi · John C. Martin Centre for Liver Research & Innovations (JCMLRI), Kolkata · Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow · Dayanand Medical College and Hospital, Ludhiana · Fortis Hospital, Mohali, Mohali · Topiwala National Medical College & B. Y. L. Nair Charitable Hospital, Mumbai · Mysore Medical College, Mysore · All India Institute of Medical Sciences (AIIMS) - Nagpur, Nagpur · Midas Multispeciality Hospital Pvt.Ltd., Nagpur · All India Institute of Medical Sciences, New Delhi · Sir Ganga Ram Hospital, New Delhi · All India Institute of Medical Sciences, Rishikesh, Rishikesh · Surat Institute of Digestive Sciences Hospitals, Surat · Acharya vinoba bhave rural hospital, Wardha

  Registry updated 2026-10-08

• NCT06374875

  Fibrosis Lessens After Metabolic Surgery

  Trial Treatment · Phase 4 · The Cleveland Clinic

  Sri Aurobindo Institute of Medical Sciences, Indore · The Digestive Health Institute, Mumbai

  Registry updated 2026-07-31

• NCT07685353

  Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant

  Research · Institute of Liver and Biliary Sciences, India

  Institute of Liver and Biliary Sciences, New Delhi

  Registry updated 2026-07-21

• NCT07585526

  Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.

  Trial Treatment · Institute of Liver and Biliary Sciences, India

  Institute of Liver and Biliary Sciences, New Delhi

  Registry updated 2026-05-13

• NCT07452744

  Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease

  Trial Treatment · Bioagile Therapeutics Pvt. Ltd.

  PGIMER, Chandigarh · King George 's Medical University, Chowk · All India Institute of Medical Sciences, Delhi · King Edward Memorial Hospital, Mumbai · NIZAM'S Institute of Medical Sciences, Panjagutta · Institute of Liver and Biliary Sciences, Vasant Kunj

  Registry updated 2026-03-12

• NCT06015620

  Comorbidities Resolution After MGB Surgery and Change in Body Composition

  Research · All India Institute of Medical Sciences, Bhubaneswar

  All India Institute of Medical Sciences, Bhubaneswar

  Registry updated 2026-02-18

• NCT06768216

  Effect of Indianized Version of Mediterranean Diet vs. Low Fat Diet on Hepatic Steatosis in Overweight Children and Adolescent With MASLD

  Trial Treatment · Institute of Liver and Biliary Sciences, India

  Institute of Liver & Biliary Sciences, New Delhi

  Registry updated 2026-01-06

• NCT06035874

  Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

  Trial Treatment · Medanta, The Medicity, India

  Division Of Endocrinology , Medanta The Medicity Sec 38, Gurgaon

  Registry updated 2025-06-13

• NCT06386094

  Cardiac Dysfunction in Patients with Fatty Liver Disease

  Research · Post Graduate Institute of Medical Education and Research, Chandigarh

  Dr. Madhumita Premkumar, Chandigarh

  Registry updated 2025-01-29

• NCT06749704

  Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLD

  Trial Treatment · Institute of Liver and Biliary Sciences, India

  Institute of Liver and Biliary Sciences, Delhi

  Registry updated 2024-12-27

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error